Sarbjit Singh Saini MD
Asthma & Allergic Conditions
Professor of Medicine, Johns Hopkins University School of Medicine Director, Allergy and Immunology Fellowship Program
Join to view full profile
5501 Hopkins Bayview CircleAllergy & Asthma Center, 2nd FloorBaltimore, MD 21224
Phone+1 410-550-2300
Fax+1 410-550-3256
Dr. Saini is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sarbjit Saini, based in Baltimore, MD, specializes in Allergy & Immunology with a subspecialty in asthma and allergic conditions. He completed his fellowship in Allergy and Immunology at Johns Hopkins University and his residency in Internal Medicine at the University of Michigan. Dr. Saini is an experienced researcher with multiple publications on chronic urticaria and its treatments, including studies on ligelizumab, omalizumab, and remibrutinib. He has been involved in clinical trials focusing on chronic idiopathic urticaria and peanut allergy. Dr. Saini's work has earned him certifications in CMS Meaningful Use from Epic Systems Corporation.
Education & Training
Johns Hopkins UniversityFellowship, Allergy and Immunology, 1994 - 1997
University of MichiganResidency, Internal Medicine, 1991 - 1994
Ohio State University College of MedicineClass of 1991
Certifications & Licensure
FL State Medical License 2020 - Present
MD State Medical License 1995 - 2027
MI State Medical License 1993 - 1997
American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- IgE antibody heterogeneity in chronic spontaneous urticaria and response to omalizumab.Jennifer M Roper, Robert G Hamilton, Christian Lupinek, Melanie C Dispenza, Sarbjit S Saini
Annals of Allergy, Asthma & Immunology. 2026-11-01 - Comparative efficacy and safety of antihistamines, increased antihistamine dosing, and antihistamine adjuncts for chronic urticaria: a systematic review, dose-response...Alexandro W L Chu, Irene X Zhao, Daniel G Rayner, Gordon H Guyatt, Ming Liu
The Journal of Allergy and Clinical Immunology. 2026-10-16 - Remibrutinib impact on disease control, sleep, and quality of life: Analysis of phase 3 REMIX-1/2.Giselle Mosnaim, Sarbjit Saini, Mark Lebwohl, Simon F Thomsen, John Reed
Annals of Allergy, Asthma & Immunology. 2026-09-01
Other
- Chronic urticaria: Clinical manifestations, diagnosis, pathogenesis, and natural historySaini S
http://www.uptodate.com/contents/chronic-urticaria-clinical-manifestations-diagnosis-pathogenesis-an
UpToDate, Wolters Kluwer Health - 2013-01-28
Press Mentions
Hereditary Angioedema Pipeline Holding up Long-TermNovember 11th, 2025- Novel BTK Inhibitor for Chronic Hives Wins in Phase III TrialNovember 16th, 2023
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/sarbjit-saini
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: